Theragenics and Clarity Pharmaceuticals Partner to Enable Scalable Copper-64 Supply for Next-Generation Diagnostics March 25, 2026
Randomized Trial Supports Dose-De-Escalated Pd-103 LDR Brachytherapy for Low-Risk Prostate Cancer January 7, 2026
Theragenics Brachytherapy is headed to the 36th Annual International Prostate Cancer Update December 5, 2025
ABS GYN and Prostate Brachytherapy Hands-On Workshop from Fundamentals to Advanced Practice September 15, 2025
